Shorts

The 2024 MS Diagnostic Criteria: More Than a Definition Update
1:00
The 2024 MS Diagnostic Criteria: More Than a Definition Update
4 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)
Building a Path Toward Neuropathy Reversal
0:35
Building a Path Toward Neuropathy Reversal
4 months ago
by
Brian Callaghan, MD, MS
Diagnosis Is Not the Same as Treatment in Multiple Sclerosis
1:02
Diagnosis Is Not the Same as Treatment in Multiple Sclerosis
4 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)
How Biomarkers Can Help Clarify the MS Diagnostic Gray Zone
1:46
How Biomarkers Can Help Clarify the MS Diagnostic Gray Zone
4 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)
RECAP: Neurology News Network - July 4th
1:17
RECAP: Neurology News Network - July 4th
4 months ago
by
Louie Pasculli
Debunking Nerve Pain Myths
0:56
Debunking Nerve Pain Myths
4 months ago
by
Mitzi Joi Williams, MD
Incorporating Biomarkers as Clinical End Points in Nerve Disorder Trials
2:00
Incorporating Biomarkers as Clinical End Points in Nerve Disorder Trials
4 months ago
by
Brett Morrison, MD, PhD
MicroRNAs Emerge as Promising Biomarkers for Diabetic Neuropathy
2:07
MicroRNAs Emerge as Promising Biomarkers for Diabetic Neuropathy
4 months ago
by
Brett Morrison, MD, PhD
RECAP: Neurology News Network - June 27th
1:39
RECAP: Neurology News Network - June 27th
5 months ago
by
Louie Pasculli
SLEEP 2026: Media Training Workshop on Sleep Science
2:06
SLEEP 2026: Media Training Workshop on Sleep Science
5 months ago
by
Julie Flygare, JD(+1 more)
ATMRD 2026: Understanding Demoralization in Parkinson Disease
1:03
ATMRD 2026: Understanding Demoralization in Parkinson Disease
5 months ago
by
Indu Subramanian, MD(+1 more)
PNS 2026: Debate Between iPSC and Animal Models for Neuropathy Research
2:06
PNS 2026: Debate Between iPSC and Animal Models for Neuropathy Research
5 months ago
by
Ahmet Hoke, MD, PhD
AHS 2026: Real-World INFUSE Trial of Eptinezumab in Migraine
1:13
AHS 2026: Real-World INFUSE Trial of Eptinezumab in Migraine
5 months ago
by
Amaal J. Starling, MD(+1 more)
SLEEP 2026: Phase 2 Study of Alixorexton in Narcolepsy Type 2
1:06
SLEEP 2026: Phase 2 Study of Alixorexton in Narcolepsy Type 2
5 months ago
by
Richard Bogan, MD, FCCP, FAASM(+1 more)
Adapting Exercise for Neurologic Conditions
0:50
Adapting Exercise for Neurologic Conditions
5 months ago
by
Mitzi Joi Williams, MD
RECAP: Neurology News Network - June 20th
0:58
RECAP: Neurology News Network - June 20th
5 months ago
by
Louie Pasculli
Steps Needed to Make Diabetic Peripheral Neuropathy Reversible
0:35
Steps Needed to Make Diabetic Peripheral Neuropathy Reversible
5 months ago
by
Brian Callaghan, MD, MS
SLEEP 2026: Key Takeaways From New Hospital-Based Sleep Apnea Guidelines
0:57
SLEEP 2026: Key Takeaways From New Hospital-Based Sleep Apnea Guidelines
5 months ago
by
Sunil Sharma, MD(+1 more)
SLEEP 2026: What Is a Common Sleep-Related Question?
1:04
SLEEP 2026: What Is a Common Sleep-Related Question?
5 months ago
by
Beth Malow, MD, MS(+1 more)
ATMRD 2026: Overlooked Symptoms of Autonomic Dysfunction in PD
1:11
ATMRD 2026: Overlooked Symptoms of Autonomic Dysfunction in PD
5 months ago
by
Louie Pasculli(+2 more)
SLEEP 2026: AASM Guideline for Treating Chronic Insomnia
1:09
SLEEP 2026: AASM Guideline for Treating Chronic Insomnia
5 months ago
by
Salma Patel, MD(+1 more)
Biggest Misconceptions Regarding Immune-Mediated Small Fiber Neuropathy
0:35
Biggest Misconceptions Regarding Immune-Mediated Small Fiber Neuropathy
5 months ago
by
Matthew Evans, BM, BCh, DPhil
Goals for Expanding Knowledge on Programmed Axon Death
0:25
Goals for Expanding Knowledge on Programmed Axon Death
5 months ago
by
Michael Coleman, PhD
Improving Basic Science Objectives for Peripheral Nerve Disorders
0:20
Improving Basic Science Objectives for Peripheral Nerve Disorders
5 months ago
by
Carla Taveggia, PhD
Confocal Corneal Microscopy as an Emerging Biomarker for Peripheral Nerve Disorders
0:20
Confocal Corneal Microscopy as an Emerging Biomarker for Peripheral Nerve Disorders
5 months ago
by
Brett Morrison, MD, PhD
Addressing an Overlooked Gap in MS Clinical Trials
0:32
Addressing an Overlooked Gap in MS Clinical Trials
5 months ago
by
Louie Pasculli(+1 more)
Key Areas of Neuropathy Research: Keeping and Optimizing Animal Models
0:20
Key Areas of Neuropathy Research: Keeping and Optimizing Animal Models
5 months ago
by
Ahmet Hoke, MD, PhD
Underexplored, Emerging Biomarkers for ALS
0:48
Underexplored, Emerging Biomarkers for ALS
5 months ago
by
Jinsy A. Andrews, MD, MSc
Exploring the Possibility of Treating ALS in the Prodromal Stage
0:56
Exploring the Possibility of Treating ALS in the Prodromal Stage
5 months ago
by
Jinsy A. Andrews, MD, MSc
ATMRD 2026: Redefining Wellness in Parkinson Disease
1:04
ATMRD 2026: Redefining Wellness in Parkinson Disease
5 months ago
by
Louie Pasculli(+1 more)